Form 4 for MRNA Moderna
Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-13 · accession 0001127602-22-017491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-14 | 2022-06-13 | MRNA | Hoge Stephen | Pres | M - OptEx | $10.90 | +10.0K | 1.63M | +0.6% | +$109.0K |
| D | 2022-06-14 | 2022-06-13 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $123.00 | -10.0K | 1.62M | -0.6% | -$1.23M |
| DM | 2022-06-14 | 2022-06-13 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -10.0K | 62.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-13 | M | A | 5,000 | $10.90 | 1,634,231 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-13 | M | A | 5,000 | $10.90 | 1,629,231 | D | — | — | |
| 3 | Common | Common Stock | 2022-06-13 | S | D | 10,000 | $123.00 | 1,624,231 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-06-13 | M | D | 5,000 | $0.00 | 56,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-06-13 | M | D | 5,000 | $0.00 | 61,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |